Through strict exclusion criteria (e.g., excluding patients with infection, inadequate dialysis, or suboptimal EPO) and standardized clinical management (e.g., uniform dialysis protocols, guideline-based iron supplementation), we minimized the impact of iron status, infection, and dialysis adequacy on our results. The gene discussed is EPO; the disease is infection.